Skip to main content

Switzerland Innovation Park Basel Area presents Open Mic Session #1: Holmusk @ Site Novartis Campus (EN)

Are mental health problems the cancer of tomorrow?

The Switzerland Innovation Park Basel Area team invites you to join us for an online session with our Site Novartis resident Holmusk. The company is building the world’s largest Real-World Evidence (RWE) platform in behavioral health and chronic diseases to advance data-driven decision-making in mental health practice and research. This platform can also be the basis of the Digital Therapeutics of tomorrow.

Founded in 2015, Holmusk is headquartered in Singapore with offices in Basel, North Carolina, New York City, London, Malaysia and Shanghai. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort.

During this session, led by our Community Manager Rahel Schneider, you will get the chance to learn about Holmusk’s platform and network with innovators in our healthcare and digital health community.

Participation is free, however registration is required before February 10th, 2021.



Rahel Schneider, Switzerland Innovation Park Basel Area


Holmusk’s role in the HC ecosystem
Stefan Suter, Head of Holmusk Europe


Holmusk solving the evidence gap in mental health
Rashmi Patel, Holmusk


Real World Evidence at our fingertips – NeuroBlu demo
Jordan Abdi, Holmusk




Networking 1:1


Voluntary exploration of the Expo-Booths

Our partner